S C Larsson et al, 2017. Modifiable pathways in Alzheimer' s disease: Mendelian randomisation analysis, British Medical Journal, published online.
I Y Kim et al, 2017. Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use, Journal of Parkinson's Disease, published online.
R Wierzejska, 2017. Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review, Archives of Medical Science, Volume 13 (3)
Y H Chuang et al, 2017. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2, Neuroepidemiology, Volume 47.
A Ascherio & M A Schwarzscild, 2016. The epidemiology of Parkinson's disease: risk factors and prevention, Lancet Neurology, published online.
I Driscoll et al, 2016. Relationship Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study, J Gerontol A Biol Sci, published online.
M Moccia et al, 2016. Caffeine Consumption and the 4-Year Progression of de Novo Parkinson's disease. Parkinsonism and Related Disorders, published online ahead of print.
L Wu et al, 2016. Coffee Intake and the Incident Risk of Cognitive Disorders: A Dose-response Meta-Analysis of Nine Prospective Cohort Studies. Clinical Nutrition, published online ahead of print.
H Nakaguchi et al, 2016. Relationship between Silent Brain Infarction and Amount of Daily Coffee Consumption in Middle Age, Journal of Stroke and Cerebrovascular Disease, published online ahead of print.
J J Ferreira et al, 2016. Espresso Coffee for the Treatment of Somnolence in Parkinson's disease: results of the n-of-1 trials. Frontiers in Neurology, published online ahead of print.
This information is intended for Healthcare professional audiences.
Please consider the environment before printing.